Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management?

Marina Noris; Giuseppe Remuzzi

doi:10.1038/ncpneph0018

Related publications

Article2007

Screening for Complement System Abnormalities in Patients with Atypical Hemolytic Uremic Syndrome

David Kavanagh, Anna Richards, Véronique Frémeaux‐Bacchi, Marina Noris, Timothy H.J. Goodship, Giuseppe Remuzzi, John P. Atkinson

Article2001

Complement factor H and hemolytic uremic syndrome

Peter F. Zipfel, Christine Skerka, Jessica Caprioli, Tamara Manuelian, Hartmut H.P. Neumann, Marina Noris, Giuseppe Remuzzi

Article2016

Genetic Atypical Hemolytic-Uremic Syndrome

Marina Noris, Elena Bresin, Caterina Mele, Giuseppe Remuzzi

Article2013

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Christophe Legendre, Christoph Licht, Petra Muus, Larry A. Greenbaum, Sunil Babu, Camille L. Bedrosian, Coralie Bingham, D.J. Cohen, Yahsou Delmas, K. Douglas, Frank Eitner, Thorsten Feldkamp, Denis Fouque, Richard R. Furman, Osama Gaber, Maria Herthelius, Maryvonne Hourmant, Diana Karpman, Yvon Lebranchu, Christophe Mariat, Jan Menne, Bruno Moulin, Jens Nürnberger, Masayo Ogawa, Giuseppe Remuzzi,

Article2013

Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype

Elena Bresin, Erica Rurali, Jessica Caprioli, Pilar Sánchez‐Corral, Véronique Frémeaux‐Bacchi, Santiago Rodrı́guez de Córdoba, Sheila Pinto, Timothy H.J. Goodship, Marta Alberti, David Ribes, Elisabetta Valoti, Giuseppe Remuzzi, Marina Noris